This document provides a qualification and validation matrix for a sterilization tunnel. It outlines various tests to verify performance, including air velocity, filter leakage, differential pressure, airflow visualization, conveyor speed, non-viable particle count, heat distribution, and endotoxin challenge studies. For each test, it describes the purpose, acceptance criteria, test frequency, and methodology. The goal is to ensure the sterilization tunnel achieves proper depyrogenation and sterilization through regular performance testing.
It is process of “Establishing documentary evidence that provide a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes”.
In the pharmaceutical industry, it is very important that in addition to final testing and compliance of products, it is also assured that the process will consistently produce the expected results.
Validation is action of proving in accordance with the principles of good manufacturing practices, that any procedure, process, equipment, material, activity or system actually leads to expected results.
Cleaning validation is documented evidence with a high degree assurance that one can consistently clean a system or a piece of equipment to predetermined and acceptable limits.
The primary regulatory concern driving the need for cleaning validation is cross contamination of the desired drug substance either by other API from previous batch runs or by residues from the cleaning agents used.
The prime purpose of validating a cleaning process is to ensure compliance with federal and other standard regulations
1. Cross contamination with active ingredients
Contamination of one batch of product with significant levels of residual active ingredients from previous batch cannot be tolerated.
In addition to the obvious problems posed by subjecting consumers or patients to unintended contaminants, potential clinically significant synergistic interactions between pharmacologically active chemicals are a real concern.
2. Contamination with unintended materials or compounds
While inert ingredients used in drug products are generally recognized as safe for human consumption, the routine use, maintenance and cleaning of equipment's provide the potential contamination with such items as equipment parts, lubricants and chemical cleaning agents3. Microbiological contamination
Maintenance , cleaning and storage conditions may provide adventitious microorganisms with the opportunity to proliferate within the processing equipment.
It is process of “Establishing documentary evidence that provide a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes”.
In the pharmaceutical industry, it is very important that in addition to final testing and compliance of products, it is also assured that the process will consistently produce the expected results.
Validation is action of proving in accordance with the principles of good manufacturing practices, that any procedure, process, equipment, material, activity or system actually leads to expected results.
Cleaning validation is documented evidence with a high degree assurance that one can consistently clean a system or a piece of equipment to predetermined and acceptable limits.
The primary regulatory concern driving the need for cleaning validation is cross contamination of the desired drug substance either by other API from previous batch runs or by residues from the cleaning agents used.
The prime purpose of validating a cleaning process is to ensure compliance with federal and other standard regulations
1. Cross contamination with active ingredients
Contamination of one batch of product with significant levels of residual active ingredients from previous batch cannot be tolerated.
In addition to the obvious problems posed by subjecting consumers or patients to unintended contaminants, potential clinically significant synergistic interactions between pharmacologically active chemicals are a real concern.
2. Contamination with unintended materials or compounds
While inert ingredients used in drug products are generally recognized as safe for human consumption, the routine use, maintenance and cleaning of equipment's provide the potential contamination with such items as equipment parts, lubricants and chemical cleaning agents3. Microbiological contamination
Maintenance , cleaning and storage conditions may provide adventitious microorganisms with the opportunity to proliferate within the processing equipment.
Experienced Quality Professional with a demonstrated history of working in the Top leading National pharmaceutical industries (Platinum, Bosch, Getz & Nabiqasim Pharma) of pakistan. Part of WHO & PIC/S Team.
Skilled in various function of Quality Assurance, Quality Management Sysytem,Validation & Qualification as described below.
1-Deviation Management System.
2-Change Control Management System.
3-Corrective & Preventive Action(CAPA).
4-Root Cause Analysis(Investigation).
5-Self Inspection (Level-I), GMP Inspection (Level-II), Internal Audit (Level-III).
6-Quality Risk Management System.
7-Market Complaint (Product Quality Defect).
8-Product Recall (Mock Recall).
9-Product Quality Review(APQR).
10-Management Review.
11-Supplier Qualification
12-ISO (9001,14001,45001 & 17025)
13-Validation Master Plan
14-Process Validation
15-Area & Equipment Qualification
16-Cleaning Validation
17-Calibration & Verification
18-Analytical Method Validation
Batch Manufacturing Record Auditing and Sop writing along with effective training sessions reagrding GMP.GDP.GLP & GSP.
This presentation is basic knowledge about the aseptic processing and media fill validation in pharmaceutical industry and media fill procedure. How to validate aseptic process in the powder drug products , data guidance and record for media fill validation.
Aseptic / sterile- “ A state of control attained by using an aseptic work area and performing activities in a manner that precludes microbiological contamination of the exposed sterile product”
Manufacturing Control Systems. J R Controls provides control systems for the manufacturing industry. A typical control system will monitor the progress of parts through the manufacturing and finishing process.
This file is just a compilation of Validation guidance and standards collected from different sources.
It contains general strategies of Qualification, HVAC validation, Water system validation, Compressed air validation, Cleaning validation and general documentation required for these processes.
Experienced Quality Professional with a demonstrated history of working in the Top leading National pharmaceutical industries (Platinum, Bosch, Getz & Nabiqasim Pharma) of pakistan. Part of WHO & PIC/S Team.
Skilled in various function of Quality Assurance, Quality Management Sysytem,Validation & Qualification as described below.
1-Deviation Management System.
2-Change Control Management System.
3-Corrective & Preventive Action(CAPA).
4-Root Cause Analysis(Investigation).
5-Self Inspection (Level-I), GMP Inspection (Level-II), Internal Audit (Level-III).
6-Quality Risk Management System.
7-Market Complaint (Product Quality Defect).
8-Product Recall (Mock Recall).
9-Product Quality Review(APQR).
10-Management Review.
11-Supplier Qualification
12-ISO (9001,14001,45001 & 17025)
13-Validation Master Plan
14-Process Validation
15-Area & Equipment Qualification
16-Cleaning Validation
17-Calibration & Verification
18-Analytical Method Validation
Batch Manufacturing Record Auditing and Sop writing along with effective training sessions reagrding GMP.GDP.GLP & GSP.
This presentation is basic knowledge about the aseptic processing and media fill validation in pharmaceutical industry and media fill procedure. How to validate aseptic process in the powder drug products , data guidance and record for media fill validation.
Aseptic / sterile- “ A state of control attained by using an aseptic work area and performing activities in a manner that precludes microbiological contamination of the exposed sterile product”
Manufacturing Control Systems. J R Controls provides control systems for the manufacturing industry. A typical control system will monitor the progress of parts through the manufacturing and finishing process.
This file is just a compilation of Validation guidance and standards collected from different sources.
It contains general strategies of Qualification, HVAC validation, Water system validation, Compressed air validation, Cleaning validation and general documentation required for these processes.
Heating, ventilation, and air conditioning is the technology of indoor and vehicular environmental comfort. Its goal is to provide thermal comfort and acceptable indoor air quality.
Contamination Control in Cleanrooms_Dr.A. AmsavelDr. Amsavel A
Basic’s of Contamination
Sources of Contamination
Environment Specification
Elements of Cleanroom Design and Qualification
Definitions
Control of Contaminations
People, Cleaning, Environment & Material
Operation, Monitoring and Control
Documents and Records
Analysis of Volatile Organic Compounds (VOCs) in Air Using US EPA Method TO-17PerkinElmer, Inc.
EPA Method TO-171 is used to determine toxic compounds in air after they have been collected onto sorbent tubes. These tubes can either adsorb specific compounds or adsorb a broad range of compounds, quantitatively. Adsorbent tubes have many applications in the investigation of volatile organic compounds (VOCs) found in EPA Method TO-17. Examples include indoor air, fence line, stack, workplace, personal monitoring and soil gas. The type of tube used, and whether the sampling is passive or active, depends upon the need at the particular site being investigated.
This application note demonstrates that the PerkinElmer TurboMatrix™ Thermal Desorber and the PerkinElmer Clarus® SQ 8 GC/MS will meet and exceed the criteria set forth in EPA method TO-17. Detailed instrument method parameters are presented, with precision, recovery, linearity and detection limit results.
Analysis of Volatile Organic Compounds (VOCs) in Air Using U.S. EPA Method TO-17PerkinElmer, Inc.
EPA Method TO-17 is used to determine toxic compounds in air after they have been collected onto sorbent tubes. These tubes can either adsorb specific compounds or adsorb a broad range of compounds, quantitatively. Adsorbent tubes have many applications in the investigation of volatile organic compounds (VOCs) found in EPA Method TO-17. Examples include indoor air, fence line, stack, workplace, personal monitoring and soil gas. The type of tube used, and whether the sampling is passive or active, depends upon the need at the particular site being investigated. This application note demonstrates that the PerkinElmer TurboMatrix™ Thermal Desorber and the PerkinElmer Clarus® SQ 8 GC/MS will meet and exceed the criteria set forth in EPA method TO-17. Detailed instrument method parameters are presented, with precision, recovery, linearity and detection limit results.
Tube Wall Temperature Measurement On Steam Reformers - Best PracticesGerard B. Hawkins
Tube Wall Temperature Measurement On Steam Reformers - Best Practices
Temperature Measurement Techniques
Top – Fired Reformer
- Tube Temperature Measurement
- Background Temperature Measurement
Side – Fired and Terrace Wall Reformer
- Tube Temperature Measurement
- Background Temperature Measurement
Safety Considerations
An overview of diagnostic tools used in RESNET testingBill Spohn
Learn about the variety of tools and test instruments that apply in RESNET standards 310 (pending) and 380. We'll cover the proper procedures as well as pros and cons of various devices.
Similar to One slider for qualification and validation of depyrogenation and sterilization tunnel (20)
Sterilization mathematics (F0. Fphy, Fbio, Sterility Assurance (SAL) calculat...Palash Das
Sterile means free from viable microorganisms and sterilization is any physical or chemical process which destroys all life forms, with special regard to microorganisms (including bacteria and sporogenous forms) and inactivates viruses.
Therefore, the terms “sterile” and “sterilization”, in a strictly biological sense, describe the absence and, respectively, the destruction of all viable microorganisms. In other words, they are absolute terms: an object or system is either “sterile” or “non-sterile”.
The destruction of a microbial population subjected to a sterilization process follows a logarithmic progression: only a treatment of infinite duration can provide the absolute certainty that the entire microbial population has been destroyed, and that the system is sterile.
Hosting remote inspection at pharmaceutical facilities Palash Das
COVID-19 pandemic has put manufacturers, affiliates and inspectors in a new and challenging situation where it is in the public interest to continue to supply medicines while ensuring demonstrated compliance. Regulatory agencies coming with the idea for conducting remote inspection across foreign manufacturing site
A review article on visual inspection program for sterile injectable product ...Palash Das
Objective of this article is to conduct a thorough review and understanding on the manually
conduct visual inspection process for liquid Injectable products in liquid and lyophilized form
and to explore the complications identified during the routine process. Along with that
troubleshot to overcome from the challenges. Evaluation quality of product during batch
release and consider continuous process improvement opportunities.
Root cause analysis is an important part for identifying failures during investigation. This article will provide you a number of examples of fish bone diagram, which will be useful for all
Pharmaceutical professional.
Version : 00
Equipment risk management - a quality systems approachPalash Das
Refer before performing risk assessment for pharmaceutical equipment. Can be considered before preparation of User Requirement Specification. in case of existing equipment can be prepare as a part of annual risk review.
Guidance on gloves maintenance in Isolator and RABSPalash Das
A faulty glove or sleeve assembly represents a route of contamination and a critical breach of Isolator integrity. Within this article we will discuss about all these aspects.
Pharmaceutical Isolator technology in aseptic processingPalash Das
These articles describe different aspects of aseptic processing Isolator.
Isolators have been around the Pharmaceutical Industry since the early 1980s and in the Nuclear Industry (glovebox technology) since the 1950s. The intent of isolators is to create an airtight barrier or enclosure around a piece of equipment or process which provides absolute separation between the operator and product. The operator can perform tasks through half- suits or glove ports. Isolators provide a specific environment inside the isolator using HEPA filters. The environment can be positive pressure or negative, can have humidity control, oxygen control, use unidirectional airflow, and can either protect the product from the operator as with aseptic processes, or protect the operator from the product as with potent product handling. The earliest uses of aseptic isolators were for sterility testing. Sterility test isolators make up most of the aseptic isolators in use and are available in many different sizes and configurations. Sterility test isolators do not need to be installed in a classified area. No formal requirement exists for a Grade D environment, but the area should be controlled to allow only trained personnel.
This article will provide clarity on all below mentioned points,
FDA Audit - The Do and Don't List
How to Prepare for a FDA Inspection
FDA Basics for Industry > What should I expect during an inspection?
What to Expect When Being Inspected - FDA
FDA Inspections: Face the Challenge Through Proactive PreparationTips to Help You Prepare for an FDA Inspection
Inspection Readiness
US food and drug administration Indian site inspections: An experience
Dealing with a "difficult" FDA investigator
Strategies For Managing FDA Inspection Compliance Risks
Dear Readers,
Through PRES we are trying to connect with the Global Pharma community. Where we discussed, share and explore lots of pharmaceutical hot topics. Being a Pharma professional it is very difficult to get time for own to do something different other than routine responsibilities. Hope you all paraprofessionals are agreed with my views.
That’s you, the readers and followers of my blog, who always encouraged me a lot to do something different than my routine schedule. All the information are easily available web media, I am just trying too collate all those information in a single article.
I have collated the information’s broadly from the Pharmacompliancemonitor, FDA and other regulatory website for this article.
Once again I would like to thanks my readers, followers and seniors, who has encourage me a lot.
PRES Mission
To develop scientifically sound, practical, technical information and resources to advance science and regulation for the pharmaceutical industry
PRES Vision
To be the foremost global provider of science, technology, and regulatory information and education for the pharmaceutical community
Workshop On Risk Assesment by Palash Ch DasPalash Das
Risk management principles are effectively utilized in many areas of business and government including finance, insurance, occupational safety, public health, pharmacovigilance, and by agencies regulating these industries. Although there are some examples of the use of quality risk management in the pharmaceutical industry today, they are limited and do not represent the full contributions that risk management has to offer. In addition, the importance of quality systems has been recognized in the pharmaceutical industry and it is becoming evident that quality risk management is a valuable component of an effective quality system.
Pharmaceutical Company Facility PresentationPalash Das
This presentation is dedicated to all pharmaceutical organization. this can be use as a standard template for presenting your organization during audit. The concept is designed based on the sterile pharmaceutical facility.
Pharmaceutical HVAC (Heating, ventilating, and air conditioning; also heating...Palash Das
This slide is represent the HVAC design,qualification and operational approach. As we know HVAC is important system for maintaining clean room. This presentation is made based on the requirement of Pharmaceutical Industry. All parameter are considered based on the current guidelines aspect.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
One slider for qualification and validation of depyrogenation and sterilization tunnel
1. Qualification and Validation Matrix Single slider On Depyrogenation and Sterilization Tunnel Palash Chandra Das. (palash.ds@gmail.com and mail2uscgmp@gmail.com)
Study Name Pictorial demonstration Why to perform ? What to verify ? What will be the Test Frequency ?
What will be the potential cause for
failure ?
Test Methodology
Airflow Velocity
Test
The purpose of this test is to measure airflow velocity and uniformity,
and supply airflow rates through the HEPA filter.
Air velocity should be maintained within 90 fpm ± 20% of mean unit velocity for even
distribution of temperature.
6 Monthly considering a critical attribute to determine the tunnel
performance
HEPA filter integrity failure
Adjustment for air supply damper
Follow the standard ISO 14644-3
Filter system
leakage Test
The purpose of this test is to confirm that the filter system is properly
installed and that leaks have not developed during use
Photometer reading downstream of the HEPA filtration unit caused by the leakage should
be less than0.01% of the upstream challenge concentration of the aerosol 100%
6 Monthly considering a critical attribute to determine the tunnel
performance
Physical damage of filter media
Ageing/ replacement frequency
Improper installation /or alignment or/ potential
gaps between filters
The standard ISO 14644-3 suggests a penetration of 0.01% of the test challenge concentration but
allows alternative criteria to be agreed between customer and supplier. The FDA Guidance, however,
indicates that 0.01% penetration is a leak.
The ISO 14644-3 standard suggests a concentration ranging 10µg/l and 100µg/l should be used for
the photometry test method. It also suggests that concentrations lower than 20µg/l reduces sensitivity,
and concentrations over 80µg/l give filter fouling. It is best to use the lower recommended
concentration to minimize the potential for blockage or a bleed-through event.
Differential
pressure
The Tunnel zones are balanced per the manufacturer specifications.
Air does not move from dirty to clean.
Individual differential pressure of individual zone are maintain with in predefined
operational limit /or design limit
Can be monitor Daily during the batch processing with certain
logical frequency /or interval
Failure in Filter integrity will be the potential cause
Pressure balance in between Clean room/or
isolator adjacent to preheating and cool zone
N/A
Air flow
visualization
To understand and verify the uniformity and pressure cascading
To review and visualize the pressure cascade in washing to preheating , heating to
preheating and cool zone and filling to cool zone
The entry hot and cooling zones demonstrate laminar air flow.
During Initial qualification
After major modification or breakdown e.g. HEPA replace , Blower
malfunction
Periodic verification after 2-3 year , based on the risk retirement
plan
Consider all the elements mentioned under Air
velocity, Filter integrity and Differential pressure
category
Place smoke generator near pre heating zone to visualize the flow from preheating to washing area.
Place smoke generator near cool zone to visualize the flow from filling to cool zone area.
Hot zone or/ sterilization zone is more pressurized than pre heating and cool zone , therefore the
smoke flow will be both the side during entering or exit from sterilization zone
Pressure cascade will be follows,
Washing Area <Preheating zone <Sterilization zone >Cool Zone <Filling area
Tunnel Belt /
Conveyor speed
verification
Tunnel conveyor speed will help to establish a desire exposure time
under the high temperature. Both will help to achieve predefine
Depyrogenation effect.
To ensure the tunnel conveyor belt speed meets the requirements as specified by OEM
(original equipment manufacturer) design qualification, installation qualification,
operational qualification, and performance qualification, as well as annular-
qualifications. . Conveyor speed shall not vary more than 3% of the set speed
During Initial Qualification and periodic qualification Conveyer motor change or frequent trip / over load
and damage
Mark the conveyer belt and run the tunnel conveyer belt for 30 second to 1 min (check with calibrated
stop watch)
Stop the conveyor and measure with calibrated measuring scale. Perform 3 time and consider the
mean for final value
Nonviable Particle
Count (NVPC) Test
The purpose of this test is to provide a cleanliness in the supplied air.
The particle counts taken under the HEPA filter in the different zones of sterilizing tunnel
should meet the requirement of ISO 5/class A.
The oven must meet specifications for total particulates, . less than
or equal to 100 for less than 0.5 micron per ft3 or less than or
equal to 3,500 for less than 0.5 micron per m3 and 0 for 5 micron
per m3
Consider all the elements mentioned under Air
velocity, Filter integrity and Differential pressure
category
The particle count test should be performed by qualified or trained person. Start blower of the sterilizing
tunnel. Calculate the number of location need to be tested. Switch on particle counter and place the iso-
kinetic suction probes at specified location under the filter of conveyor belt of tunnel and observe the
reading, record in reports.
Empty Heat
distribution study
To understand the uniformity of empty tunnel heat distribution pattern
in empty condition. It gives confidence on the over all design and
control philosophy and shows how healthy is your tunnel.
Distribution in the tunnel less uniform than autoclave. Therefore distribution thermocouples
are within a range of ± 15.0°C or more can be appropriate consideration based on the
OEM (original equipment manufacturer) specification in design document.
During Initial Qualification and periodic qualification ( Industry
practice is once 2 yearly frequency)
After major breakdown or/ maintenance activity of heating and
conveyor system based on the risked based approach
Apart from the Qualification in alternate way this test can be
considered as maintenance check during preventive maintenance.
Failure in the heater blank
Variation/or misalignment in individual pressure
Improper air flow
Air floe within tunnel and adjoining area
Use zig plate to hold vial with the probes (sensor) in place as it help smooth travel through the tunnel.
Attach the connecting cable of probes (sensor) to data logger, which can scan the date, time and
temperature of probes at every 10 seconds.
Heat penetration
and Endotoxin
challenge study
To ensure that heat is sufficiently penetrating into the inner most
portion of the vial subjected for sterilization and Depyrogenation to
achieve desired heat Penetration and endotoxin log reduction
efficiency of the Tunnel Sterilizer
Note: Challenge thermal probe and endotoxin unit should not less than
5 unit.
Study Approach 1:
Heat penetration/load mapping study:
All the container configuration must be evaluated initially but later on container
configuration shows least FH value can be consider as worst one to challenge for periodic
qualification.
Confirmatory study for Depyrogenation:
Endotoxin study to be considered for the lowest FH configuration with least time-
temperature condition from the nominal (routine) cycle. Required to demonstrate minimum
3 log reduction. This is considered as worst case challenge to confirm Depyrogenation
efficiency.
Performance Qualification:
If time and temperature criteria is consistently meeting the require FH, then endotoxin
challenge may be leverage considering confirmatory study out come.
Study Approach 2:
All temperature measured in the chamber is ≥ 300°C. Minimum cumulative FH
location will be determined for informational purposes only. The recovery of endotoxin
concentration after in sterilization and Depyrogenation should at least 3 log reductions.
At least one heat penetration study using thermocouples will be
performed for complex load configuration. (6 monthly/or NMT 1
year)
Temperature uniformity and delivery of heat will be documented.
These studies can be combine with endotoxin challenge or
individual endotoxin studies can be performed with different
frequency identified with risk based approach.
Container enters to tunnel are wet therefore must
be evaluated for uniformity based on the drying
efficiency at washing machine by purging
compressed air to get uniform thermal input.
Container complexity must be evaluated based on
the load mass and type of container (tubular or
molded).
The temperature sensor should to be place into direct contact with the glass item at the bottom-most
the container.
Sensor should to be placed to cover the tunnel width extreme right/ left corner and middle (highest
density) to get temperature measurement across width of conveyor belt.
Get the spiked vials with approx. 10,000 EU/vial of bacterial endotoxin from microbiology. The recovery
of endotoxin concentration after exposing to Depyrogenation tunnel should show more than 3 log
reduction.
Cool Zone
sterilization
Cool Zone sterilization cycle provides better sterility assurance to avoid
the microbial contamination after sudden stoppage of machine or
breakdown /or routine maintenance program .
In routine it is recommended to switch on the tunnel in Blower
On/Night mode to maintain the Grade A (ISO 5) condition after
completion of batch activity. When machine is completely stopped for
performing preventive maintenance or sudden break down
maintenance cool zone sterilization cycle need to be considered.
Irrespective of maintenance a periodic qualification can be a way to
review and understand the reproducibility.
Temperature not less than 170 °C for 1 hr. to be observed. The most common time-
temperature relationships for sterilization with hot air sterilizers are 170 °C (340 F) for 60
minutes, 160 °C (320 F) for 120 minutes, and 150 °C (300 F) for 150 minutes.
Bacillus atrophaeus spores should be used to monitor the sterilization process for dry heat
because they are more resistant to dry heat than are G. stearothermophilus spores.
Minimum 6 log reduction of biological indicator Bacillus atrophaeus.
Options include a sterilizable cool zone for improved sterility
assurance. Industry practice for requalification is NMT 2 yr. but can
be different based on the practices and procedure followed by
individual firm.
Firm should look into all the element which can
impact the heating.
Ensure adequate closure of cool zone from
sterilization zone and filling area to reduce potential
heat loss.
Calibration of sensors and data logger.
Selection , qualification and validity of biological
indicators.
Dry heat sterilization typically done in 160-190 °C where objective is sterilization rather than
Depyrogenation. It will perform in empty condition only as expectation to sterilize the zone not the
containers.
Distribute sufficient numbers of thermocouples and Bacillus atrophaeus (ATCC No. 9372) biological
indicators throughout the conveyor in the cool zone.
Review temperature data after completion of cycle, collect the BI’s and submit the BI’s to micro for
incubation.
Revision 01 , typographical correction , dated 16 Dec 2020
Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das, M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation
Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das, M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation
Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das, M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation
Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das, M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation
Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das, M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation
Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das, M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation
Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das, M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation
Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation Palash Chandra Das, M.Pharm SME in Qualification and Validation Palash Chandra Das , M.Pharm SME in Qualification and Validation
Prepared by Das, Palash Chandra 12/16/2020 Page 1